TY - JOUR
T1 - Diagnosis and Treatment of Leishmaniasis
T2 - Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
AU - Aronson, Naomi
AU - Herwaldt, Barbara L.
AU - Libman, Michael
AU - Pearson, Richard
AU - Lopez-Velez, Rogelio
AU - Weina, Peter
AU - Carvalho, Edgar M.
AU - Ephros, Moshe
AU - Jeronimo, Selma
AU - Magill, Alan
N1 - Funding Information:
Support for these guidelines was provided by the Infectious Diseases Society of America and the American Society of Tropical Medicine and Hygiene.
Publisher Copyright:
© Copyright 2017 by The American Society of Tropical Medicine and Hygiene.
PY - 2017/1
Y1 - 2017/1
N2 - Guidelines for the clinical management of persons with leishmaniasis were prepared by a Panel of the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). The guidelines are intended for internists, pediatricians, family practitioners, and dermatologists, as well as infectious disease specialists, practicing in the United States and Canada (for simplicity, referred to here as North America). The Panel followed a guideline development process that has been adopted by IDSA, which includes a systematic method of grading both the quality of evidence (very low, low, moderate, or high) and the strength of the recommendation (weak or strong) [1] (Figure 1).
AB - Guidelines for the clinical management of persons with leishmaniasis were prepared by a Panel of the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). The guidelines are intended for internists, pediatricians, family practitioners, and dermatologists, as well as infectious disease specialists, practicing in the United States and Canada (for simplicity, referred to here as North America). The Panel followed a guideline development process that has been adopted by IDSA, which includes a systematic method of grading both the quality of evidence (very low, low, moderate, or high) and the strength of the recommendation (weak or strong) [1] (Figure 1).
KW - cutaneous leishmaniasis
KW - immunocompromised host
KW - leishmaniasis diagnostic testing
KW - mucosal leishmaniasis
KW - visceral leishmaniasis
UR - http://www.scopus.com/inward/record.url?scp=85011663064&partnerID=8YFLogxK
U2 - 10.4269/ajtmh.16-84256
DO - 10.4269/ajtmh.16-84256
M3 - Article
C2 - 27927991
AN - SCOPUS:85007394415
SN - 0002-9637
VL - 96
SP - 24
EP - 45
JO - American Journal of Tropical Medicine and Hygiene
JF - American Journal of Tropical Medicine and Hygiene
IS - 1
ER -